Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1991;69(3):349–363.

Pricing, distribution, and use of antimalarial drugs.

S D Foster 1
PMCID: PMC2393110  PMID: 1893512

Abstract

Prices of new antimalarial drugs are targeted at the "travellers' market" in developed countries, which makes them unaffordable in malaria-endemic countries where the per capita annual drug expenditures are US$ 5 or less. Antimalarials are distributed through a variety of channels in both public and private sectors, the official malaria control programmes accounting for 25-30% of chloroquine distribution. The unofficial drug sellers in markets, streets, and village shops account for as much as half of antimalarials distributed in many developing countries. Use of antimalarials through the health services is often poor; drug shortages are common and overprescription and overuse of injections are significant problems. Anxiety over drug costs may prevent patients from getting the necessary treatment for malaria, especially because of the seasonal appearance of this disease when people's cash reserves are very low. The high costs may lead them to unofficial sources, which will sell a single tablet instead of a complete course of treatment, and subsequently to increased, often irrational demand for more drugs and more injections. Increasingly people are resorting to self-medication for malaria, which may cause delays in seeking proper treatment in cases of failure, especially in areas where chloroquine resistance has increased rapidly. Self-medication is now widespread, and measures to restrict the illicit sale of drugs have been unsuccessful. The "unofficial" channels thus represent an unacknowledged extension of the health services in many countries; suggestions are advanced to encourage better self-medication by increasing the knowledge base among the population at large (mothers, schoolchildren, market sellers, and shopkeepers), with an emphasis on correct dosing and on the importance of seeking further treatment without delay, if necessary.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bledsoe C. H., Goubaud M. F. The reinterpretation of Western pharmaceuticals among the Mende of Sierra Leone. Soc Sci Med. 1985;21(3):275–282. doi: 10.1016/0277-9536(85)90101-7. [DOI] [PubMed] [Google Scholar]
  2. Deming M. S., Gayibor A., Murphy K., Jones T. S., Karsa T. Home treatment of febrile children with antimalarial drugs in Togo. Bull World Health Organ. 1989;67(6):695–700. [PMC free article] [PubMed] [Google Scholar]
  3. Fassin D. Illicit sale of pharmaceuticals in Africa: sellers and clients in the suburbs of Dakar. Trop Geogr Med. 1988 Apr;40(2):166–170. [PubMed] [Google Scholar]
  4. Greenberg A. E., Ntumbanzondo M., Ntula N., Mawa L., Howell J., Davachi F. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ. 1989;67(2):189–196. [PMC free article] [PubMed] [Google Scholar]
  5. Haak H. Pharmaceuticals in two Brazilian villages: lay practices and perceptions. Soc Sci Med. 1988;27(12):1415–1427. doi: 10.1016/0277-9536(88)90208-0. [DOI] [PubMed] [Google Scholar]
  6. Heymann D. L., Steketee R. W., Wirima J. J., McFarland D. A., Khoromana C. O., Campbell C. C. Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost. Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):496–498. doi: 10.1016/0035-9203(90)90011-3. [DOI] [PubMed] [Google Scholar]
  7. Isenalumhe A. E., Oviawe O. Polypharmacy: its cost burden and barrier to medical care in a drug-oriented health care system. Int J Health Serv. 1988;18(2):335–342. doi: 10.2190/W0VC-V1BW-WU54-CPQ5. [DOI] [PubMed] [Google Scholar]
  8. MacCormack C. P., Lwihula G. Failure to participate in a malaria chemosuppression programme: North Mara, Tanzania. J Trop Med Hyg. 1983 Jun;86(3):99–107. [PubMed] [Google Scholar]
  9. Mburu F. M., Spencer H. C., Kaseje D. C. Changes in sources of treatment occurring after inception of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol. 1987 Apr;81 (Suppl 1):105–110. doi: 10.1080/00034983.1987.11812195. [DOI] [PubMed] [Google Scholar]
  10. Menon A., Joof D., Rowan K. M., Greenwood B. M. Maternal administration of chloroquine: an unexplored aspect of malaria control. J Trop Med Hyg. 1988 Apr;91(2):49–54. [PubMed] [Google Scholar]
  11. Raynal A. L. Use of over-the-counter medications in rural Matabeleland, Zimbabwe: the case for upgrading the dispensing skills of rural storekeepers. Cent Afr J Med. 1985 May;31(5):92–97. [PubMed] [Google Scholar]
  12. Stein C. M., Gora N. P., Macheka B. M. Self-medication with chloroquine for malaria prophylaxis in urban and rural Zimbabweans. Trop Geogr Med. 1988 Jul;40(3):264–268. [PubMed] [Google Scholar]
  13. Taylor D. The pharmaceutical industry and health in the Third World. Soc Sci Med. 1986;22(11):1141–1149. doi: 10.1016/0277-9536(86)90180-2. [DOI] [PubMed] [Google Scholar]
  14. van der Geest S. Self-care and the informal sale of drugs in south Cameroon. Soc Sci Med. 1987;25(3):293–305. doi: 10.1016/0277-9536(87)90232-2. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES